The use of lipid-lowering agents in HIV-infected patients.
Meienberg
F
F
Basel Center for HIV Research, Outpatient Department of Internal Medicine, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
Battegay
E
E
Bucher
H C
HC
Battegay
M
M
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001161:Arteriosclerosis / Q000188:drug therapy / Q000517:prevention & control; D018752:Diet, Fat-Restricted; D004347:Drug Interactions; D015444:Exercise; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D000960:Hypolipidemic Agents